Sequent Scientific up 9% on EUGMP nod for its tablets dosage form in Turkey

Shares of Sequent Scientific moved higher by 9 per cent to Rs 293 on the BSE in intra-day trade on Thursday amid heavy volumes after the company announced the EUGMP approval for its tablets dosage manufacturing line in Turkey. The trading volumes on the counter jumped over four-fold, with a combined 5 million equity shares having changed hands on the NSE and BSE till 02:03 pm.

With over 120 product registrations, Sequent is the third-largest player in the Turkish ruminant market with a consolidated market share of around 10 per cent, operating through its 100 per cent subsidiaries of Provet and